DMR-002

N/A

Report date: 2025/11/25 09:40:11

Base Information

Drug NameDMR-002
Drug Alias NameDMR-002DMR002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Calreticulin
TargetsCalreticulin
Therapy Area/IndicationsMyeloproliferative Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDamora Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDamora Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyeloproliferative Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A